Aveo Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
Complete Sustainability analysis of Aveo Pharmaceuticals Inc are reached by signing in. The ESG rating includes seventeen United Nations SDGs including: 'No Poverty', 'Climate Action' and 'Life on Land'. The webpage of Aveo Pharmaceuticals Inc was assembled by All Street Sevva using cutting edge AI.
Aveo Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.3; made up of an environmental score of 4.0, social score of 2.7 and governance score of 5.7.
4.3
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 1284 | Sinopep Allsino Bio Pharmaceutical Co Ltd | 4.4 | High |
| 1284 | Vanda Pharmaceuticals Inc | 4.4 | High |
| 1335 | Aveo Pharmaceuticals Inc | 4.3 | High |
| 1335 | Angion Biomedica Corp | 4.3 | High |
| 1335 | AddLife AB | 4.3 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Aveo Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Aveo Pharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Aveo Pharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes Aveo Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Aveo Pharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Aveo Pharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Aveo Pharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes Aveo Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Aveo Pharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Aveo Pharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes Aveo Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Aveo Pharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Aveo Pharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Aveo Pharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Aveo Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Aveo Pharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes Aveo Pharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Aveo Pharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes Aveo Pharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Aveo Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Aveo Pharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Aveo Pharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes Aveo Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Aveo Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Aveo Pharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Aveo Pharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Aveo Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Aveo Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Aveo Pharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Aveo Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Aveo Pharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes Aveo Pharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes Aveo Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Aveo Pharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes Aveo Pharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Aveo Pharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Aveo Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
AVEO Pharmaceuticals, Inc., an oncology-focused biopharmaceutical company, focuses on developing and commercializing medicines for patients with cancer. It markets FOTIVDA, an oral, next-generation vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of adult patients with relapsed or refractory advanced renal cell carcinoma (RCC). The company is also developing tivozanib for the treatment of RCC, hepatocellular carcinoma, ovarian cancer, immunologically cold tumors, and cholangiocarcinoma. In addition, it is developing Ficlatuzumab, a potent humanized immunoglobulin G1 (IgG1) monoclonal antibody that targets hepatocyte growth factor that is in a Phase II clinical trial for the treatment of head and neck squamous cell carcinoma, pancreatic cancer, and acute myeloid leukemia; AV-380, a potent humanized IgG1 inhibitory monoclonal antibody for the treatment or prevention of cachexia; AV-203, a potent humanized IgG1 monoclonal antibody that targets ErbB3; and AV-353 that targets the Notch 3 pathway. The company has collaborations and license agreements with AstraZeneca PLC; EUSA Pharma (UK) Limited; Biodesix, Inc.; CANbridge Life Sciences, Ltd.; Biogen Idec International GmbH; St. Vincent's Hospital Sydney Limited; and Kyowa Kirin Co., Ltd. The company was formerly known as GenPath Pharmaceuticals, Inc. and changed its name to AVEO Pharmaceuticals, Inc. in March 2005. AVEO Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Boston, Massachusetts.